A Clinical Trial to study the effects of two nutritional supplements, protein supplement and immuno-nutritional supplement in the patients with Oral squamous cell carcinoma.
- Conditions
- Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
- Registration Number
- CTRI/2020/11/029442
- Lead Sponsor
- Department of Oral and Maxillofacial Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Participants of both the genders in the age group of 18-70 years.
2. Participants with Oral Squamous Cell Carcinoma who will undergo surgical resection of the tumor.
3. Participants with Oral Squamous Cell Carcinoma who will undergo surgical resection of the tumor with chemotherapy and/or Radiotherapy.
4. Participants in whom the planned surgery will be performed for duration of 4-6 hours.
5. Participants willing for study.
1. Participants who have upper arm deformities.
2. Participants who are declared inoperable and are planned for palliative cancer therapies like radiotherapy and chemotherapy.
3. Participants in whom upper limb skin/flap is used for reconstruction purpose.
4. Participants who are a recurrence case of oral squamous cell carcinoma.
5. Participants who have undergone previous major surgeries under GA.
6. Participants presently suffering from a condition other than oral squamous cell carcinoma that also requires surgical intervention.
7. Participants who have a Renal Disorders and risen levels of Serum Creatinine.
8. Participants who have uncontrolled Diabetes.
9. Participants in whom the surgery will be undertaken for more than 6 hours.
10. Participants with Severe Sepsis.
11. ICU patients with severe illness who do not tolerate more than 700ml enteral feed per day.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method